Trial Profile
Post-Marketing Surveillance of Bravonto in Korea
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- 05 Mar 2013 New trial record